Drug Resistance Mechanisms

Research in drug resistance mechanisms investigates how diseases, particularly cancers and infectious agents, evade the effects of therapeutic drugs. Studies explore the molecular and cellular processes that enable resistance, including genetic mutations, altered drug metabolism, and the activation of survival pathways. This work employs a range of techniques, from cell-based assays and genetic sequencing to advanced imaging and computational modeling, to identify specific targets and pathways involved in drug failure. Areas of focus include understanding resistance in specific cancer types, such as hepatocellular carcinoma and gastric adenocarcinoma, as well as mechanisms relevant to infectious diseases.

This research holds significant relevance for Arkansas by addressing critical public health challenges and supporting the state's growing biosciences sector. Understanding drug resistance is essential for improving treatment outcomes for Arkansans affected by cancer and infectious diseases, potentially reducing healthcare burdens. Furthermore, insights gained can inform the development of new therapeutic strategies and diagnostic tools, contributing to innovation within the state's pharmaceutical and biotechnology industries.

This area intersects with studies in pharmacology, molecular biology, and specific cancer research fields. Engagement across institutions facilitates a comprehensive approach to understanding and overcoming drug resistance.